{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["amino acid", "anti-angiogenesis", "autophagy", "human colorectal cancer cell", "tetrandrine derivatives"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35807286", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "23"}], "Language": ["eng"], "ELocationID": ["4040", "10.3390/molecules27134040"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "13", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "23"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer.", "Abstract": {"AbstractText": ["As a typical dibenzylisoquinoline alkaloid, tetrandrine (TET) is clinically used for the treatment of silicosis, inflammatory pulmonary, and cardiovascular diseases in China. Recent investigations have demonstrated the outstanding anticancer activity of this structure, but its poor aqueous solubility severely restricts its further development. Herein, a series of its 14-<i>N</i>-amino acid-substituted derivatives with improved anticancer effects and aqueous solubility were designed and synthesized. Among them, compound <b>16</b> displayed the best antiproliferative activity against human colorectal cancer (HCT-15) cells, with an IC<sub>50</sub> value of 0.57 \u03bcM. Compared with TET, <b>16</b> was markedly improved in terms of aqueous solubility (by 5-fold). Compound <b>16</b> significantly suppressed the colony formation, migration, and invasion of HCT-15 cells in a concentration-dependent manner, with it being more potent in this respect than TET. Additionally, compound <b>16</b> markedly impaired the morphology and motility of HCT-15 cells and induced the death of colorectal cancer cells in double-staining and flow cytometry assays. Western blot results revealed that <b>16</b> could induce the autophagy of HCT-15 cells by significantly decreasing the content of p62/SQSTM1 and enhancing the Beclin-1 level and the ratio of LC3-II to LC3-I. Further study showed that <b>16</b> effectively inhibited the proliferation, migration, and tube formation of umbilical vein endothelial cells, manifesting in a potent anti-angiogenesis effect. Overall, these results revealed the potential of <b>16</b> as a promising candidate for further preclinical studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Wang", "ForeName": "Yu-Chan", "Initials": "YC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Zhang", "ForeName": "Rong-Hong", "Initials": "RH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Hu", "ForeName": "Sheng-Cao", "Initials": "SC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Zhang", "ForeName": "Hong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Yang", "ForeName": "Dan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Zhang", "ForeName": "Wen-Li", "Initials": "WL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Zhao", "ForeName": "Yong-Long", "Initials": "YL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Cui", "ForeName": "Dong-Bing", "Initials": "DB"}, {"Identifier": ["0000-0002-0479-6259"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Li", "ForeName": "Yong-Jun", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Pan", "ForeName": "Wei-Dong", "Initials": "WD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Liao", "ForeName": "Shang-Gao", "Initials": "SG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China."}], "LastName": "Zhou", "ForeName": "Meng", "Initials": "M"}], "GrantList": [{"GrantID": "81960635, 81660570 and U1812403-05", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "[2018]5779-13, [2018]5779-75, and 20NSP076", "Agency": "Guizhou Medical University Academic New Seedling Training and Innovation Exploration Project", "Country": ""}, {"GrantID": "QKHJC [2020]1Z008, QKHJC-ZK[2021]551, QKHZC [2021]425, 2020-5006, and 2020-6011", "Agency": "Guizhou Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amino Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylisoquinolines"}, {"RegistryNumber": "29EX23D5AJ", "NameOfSubstance": "tetrandrine"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Amino Acids"}, {"QualifierName": ["chemistry"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Benzylisoquinolines"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Colorectal Neoplasms"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "The authors confirm that the content of this article has no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Torre L.A., Siegel R.L., Ward E.M., Jemal A. Global Cancer Incidence and Mortality Rates and Trends\u2014An Update. Cancer Epidemiol. Biomark. Prev. 2016;25:16\u201327. doi: 10.1158/1055-9965.EPI-15-0578.", "ArticleIdList": ["10.1158/1055-9965.EPI-15-0578", "26667886"]}, {"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011;61:69\u201390. doi: 10.3322/caac.20107.", "ArticleIdList": ["10.3322/caac.20107", "21296855"]}, {"Citation": "De Sousa E.M.F., Wang X., Jansen M., Fessler E., Trinh A., de Rooij L.P., de Jong J.H., de Boer O.J., van Leersum R., Bijlsma M.F., et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat. Med. 2013;19:614\u2013618. doi: 10.1038/nm.3174.", "ArticleIdList": ["10.1038/nm.3174", "23584090"]}, {"Citation": "Liu J.P., Wei H.B., Zheng Z.H., Guo W.P., Fang J.F. Celecoxib increases retinoid sensitivity in human colon cancer cell lines. Cell. Mol. Biol. Lett. 2010;15:440\u2013450. doi: 10.2478/s11658-010-0016-2.", "ArticleIdList": ["10.2478/s11658-010-0016-2", "PMC6275995", "20496179"]}, {"Citation": "Weitz J., Koch M., Debus J., H\u00f6hler T., Galle P.R., B\u00fcchler M.W. Colorectal cancer. Lancet. 2005;365:153\u2013165. doi: 10.1016/S0140-6736(05)17706-X.", "ArticleIdList": ["10.1016/S0140-6736(05)17706-X", "15639298"]}, {"Citation": "Zhang R.H., Wang S., Zhang H., Lan J.J., Xu G.B., Zhao Y.L., Wang L., Li Y.J., Wang Y.L., Zhou Y.H., et al. Discovery of tetrandrine derivatives as tumor migration, invasion and angiogenesis inhibitors. Bioorg. Chem. 2020;101:104025. doi: 10.1016/j.bioorg.2020.104025.", "ArticleIdList": ["10.1016/j.bioorg.2020.104025", "32599368"]}, {"Citation": "Pretzsch E., B\u00f6sch F., Neumann J., Ganschow P., Bazhin A., Guba M., Werner J., Angele M. Mechanisms of metastasis in colorectal cancer and metastatic organotropism: Hematogenous versus peritoneal spread. J. Oncol. 2019;2019:7407190. doi: 10.1155/2019/7407190.", "ArticleIdList": ["10.1155/2019/7407190", "PMC6770301", "31641356"]}, {"Citation": "Na H., Liu X., Li X., Zhang X., Wang Y., Wang Z., Yuan M., Zhang Y., Ren S., Zuo Y. Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis. J. Hematol. Oncol. 2017;10:28. doi: 10.1186/s13045-016-0383-x.", "ArticleIdList": ["10.1186/s13045-016-0383-x", "PMC5251210", "28109307"]}, {"Citation": "Tan H.T., Wu W., Ng Y.Z., Zhang X., Yan B., Ong C.W., Tan S., Salto-Tellez M., Hooi S.C., Chung M.C.M. Proteomic analysis of colorectal cancer metastasis: Stathmin-1 revealed as a player in cancer cell migration and prognostic marker. J. Proteome Res. 2012;11:1433\u20131445. doi: 10.1021/pr2010956.", "ArticleIdList": ["10.1021/pr2010956", "22181002"]}, {"Citation": "Rmali K.A., Puntis M.C., Jiang W.G. Tumour-associated angiogenesis in human colorectal cancer. Colorectal Dis. 2007;9:3\u201314. doi: 10.1111/j.1463-1318.2006.01089.x.", "ArticleIdList": ["10.1111/j.1463-1318.2006.01089.x", "17181841"]}, {"Citation": "Paulo A., Moreira R., Lavrado J. Indoloquinolines as scaffolds for drug discovery. Curr. Med. Chem. 2010;17:2348\u20132370.", "ArticleIdList": ["20491639"]}, {"Citation": "Veeresham C. Natural products derived from plants as a source of drugs. J. Adv. Pharm. Technol. Res. 2012;3:200\u2013201. doi: 10.4103/2231-4040.104709.", "ArticleIdList": ["10.4103/2231-4040.104709", "PMC3560124", "23378939"]}, {"Citation": "Burns A., Jacoby R. Dimebon in Alzheimer\u2019s disease: Old drug for new indication. Lancet. 2008;372:179\u2013180. doi: 10.1016/S0140-6736(08)61046-6.", "ArticleIdList": ["10.1016/S0140-6736(08)61046-6", "18640436"]}, {"Citation": "Chinembiri T.N., du Plessis L.H., Gerber M., Hamman J.H., du Plessis J. Review of natural compounds for potential skin cancer treatment. Molecules. 2014;19:11679\u201311721. doi: 10.3390/molecules190811679.", "ArticleIdList": ["10.3390/molecules190811679", "PMC6271439", "25102117"]}, {"Citation": "Islam M.R., Islam F., Nafady M.H., Akter M., Mitra S., Das R., Urmee H., Shohag S., Akter A., Chidambaram K., et al. Natural small molecules in breast cancer treatment: Understandings from a therapeutic viewpoint. Molecules. 2022;27:2165. doi: 10.3390/molecules27072165.", "ArticleIdList": ["10.3390/molecules27072165", "PMC9000328", "35408561"]}, {"Citation": "Huang H., Yao Y., He Z., Yang T., Ma J., Tian X., Li Y., Huang C., Chen X., Li W. Antimalarial \u03b2-carboline and indolactam alkaloids from marinactinospora thermotolerans, a deep sea isolate. J. Nat. Prod. 2011;74:2122\u20132127. doi: 10.1021/np200399t.", "ArticleIdList": ["10.1021/np200399t", "21977916"]}, {"Citation": "Bhagya N., Chandrashekar K.R. Tetrandrine-A molecule of wide bioactivity. Phytochemistry. 2016;125:5\u201313. doi: 10.1016/j.phytochem.2016.02.005.", "ArticleIdList": ["10.1016/j.phytochem.2016.02.005", "26899361"]}, {"Citation": "Liu T., Liu X., Li W. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget. 2016;7:40800\u201340815. doi: 10.18632/oncotarget.8315.", "ArticleIdList": ["10.18632/oncotarget.8315", "PMC5130046", "27027348"]}, {"Citation": "Kuo P.-L., Lin C.-C. Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. Life Sci. 2003;73:243\u2013252. doi: 10.1016/S0024-3205(03)00266-2.", "ArticleIdList": ["10.1016/S0024-3205(03)00266-2", "12738038"]}, {"Citation": "Guo Y., Pei X. Tetrandrine-induced autophagy in MDA-MB-231 triple-negative breast cancer cell through the inhibition of PI3K/AKT/mTOR Signaling. Evid.-Based Complement. Altern. Med. 2019;2019:7517431. doi: 10.1155/2019/7517431.", "ArticleIdList": ["10.1155/2019/7517431", "PMC6332987", "30713576"]}, {"Citation": "Zhou Y., Mu L., Liu X.L., Li Q., Ding L.X., Chen H.C., Hu Y., Li F.S., Sun W.J., He B.C., et al. Tetrandrine inhibits proliferation of colon cancer cells by BMP9/PTEN/PI3K/AKT signaling. Genes Dis. 2021;8:373\u2013383. doi: 10.1016/j.gendis.2019.10.017.", "ArticleIdList": ["10.1016/j.gendis.2019.10.017", "PMC8093580", "33997184"]}, {"Citation": "Shishodia G., Koul S., Dong Q., Koul H.K. Tetrandrine (TET) Induces death receptors apo trail R1 (DR4) and apo trail R2 (DR5) and sensitizes prostate cancer cells to TRAIL-induced apoptosis. Mol. Cancer Ther. 2018;17:1217\u20131228. doi: 10.1158/1535-7163.MCT-17-1157.", "ArticleIdList": ["10.1158/1535-7163.MCT-17-1157", "29549167"]}, {"Citation": "Wu J.-M., Chen Y., Chen J.-C., Lin T.-Y., Tseng S.-H. Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Lett. 2010;287:187\u2013195. doi: 10.1016/j.canlet.2009.06.009.", "ArticleIdList": ["10.1016/j.canlet.2009.06.009", "19586712"]}, {"Citation": "He B.C., Gao J.L., Zhang B.Q., Luo Q., Shi Q., Kim S.H., Huang E., Gao Y., Yang K., Wagner E.R., et al. Tetrandrine inhibits Wnt/\u03b2-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol. Pharmacol. 2011;79:211\u2013219. doi: 10.1124/mol.110.068668.", "ArticleIdList": ["10.1124/mol.110.068668", "PMC3033706", "20978119"]}, {"Citation": "Lee H.-S., Kim D.H., Lee I.-S., Park J.-H., Martin G., Safe S., Kim K.-J., Kim J.-H., Jang B.I., Lee S.-O. Plant alkaloid tetrandrine is a nuclear receptor 4A1 antagonist and inhibits Panc-1 cell growth in vitro and in vivo. Int. J. Mol. Sci. 2022;23:5280. doi: 10.3390/ijms23095280.", "ArticleIdList": ["10.3390/ijms23095280", "PMC9104798", "35563670"]}, {"Citation": "Shang W., Zhang J., Song H., Zhu S., Zhang A., Hua Y., Han S., Fu Y. Mechanism of tetrandrine against endometrial cancer based on network pharmacology. Drug Des. Dev. Ther. 2021;15:2907\u20132919. doi: 10.2147/DDDT.S307670.", "ArticleIdList": ["10.2147/DDDT.S307670", "PMC8275110", "34262258"]}, {"Citation": "Wong V.K.W., Zeng W., Chen J., Yao X.J., Leung E.L.H., Wang Q.Q., Chiu P., Ko B.C.B., Law B.Y.K. Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-\u03b1 inhibition and mTOR-dependent mechanisms. Front. Pharmacol. 2017;8:351. doi: 10.3389/fphar.2017.00351.", "ArticleIdList": ["10.3389/fphar.2017.00351", "PMC5462963", "28642707"]}, {"Citation": "Liao D., Zhang W., Gupta P., Lei Z.N., Wang J.Q., Cai C.Y., Vera A.A., Zhang L., Chen Z.S., Yang D.H. Tetrandrine interaction with ABCB1 Reverses multidrug resistance in cancer cells through competition with anti-cancer drugs followed by downregulation of ABCB1 expression. Molecules. 2019;24:4383. doi: 10.3390/molecules24234383.", "ArticleIdList": ["10.3390/molecules24234383", "PMC6930469", "31801248"]}, {"Citation": "Tian Y., Yin H., Xu H. Enhanced pro-apoptotic effect of tetrandrine loaded nanoparticles against osteosarcoma cells. Curr. Drug Deliv. 2016;13:946\u2013952. doi: 10.2174/1567201813666160303104439.", "ArticleIdList": ["10.2174/1567201813666160303104439", "26935259"]}, {"Citation": "Yang Q.H., Jiang C.S., Jin T., Xu J.F., Qu T.L., Guo Y.W., Zhao Z.B. Synthesis of novel tetrandrine derivatives and their inhibition against NSCLC A549 cells. Asian Nat. Prod. Res. 2018;20:1064\u20131074. doi: 10.1080/10286020.2018.1478817.", "ArticleIdList": ["10.1080/10286020.2018.1478817", "29852780"]}, {"Citation": "Song J., Lan J., Chen C., Hu S., Song J., Liu W., Zeng X., Lou H., Ben-David Y., Pan W. Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents. MedChemComm. 2018;9:1131\u20131141. doi: 10.1039/C8MD00125A.", "ArticleIdList": ["10.1039/C8MD00125A", "PMC6072089", "30109000"]}, {"Citation": "Lan J., Wang N., Huang L., Liu Y., Ma X., Lou H., Chen C., Feng Y., Pan W. Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma. Eur. J. Med. Chem. 2017;127:554\u2013566. doi: 10.1016/j.ejmech.2017.01.008.", "ArticleIdList": ["10.1016/j.ejmech.2017.01.008", "28109948"]}, {"Citation": "Liu Y., Huang L., Sun Q., Zhang M., Li T., Liang G., Pan W. Syntheses and anti-cancer activities of derivatives of tetrandrine and fangchinoline. Chem. Res. Chin. Univ. 2014;30:937\u2013940. doi: 10.1007/s40242-014-4240-6.", "ArticleIdList": ["10.1007/s40242-014-4240-6"]}, {"Citation": "Li D., Liu H., Liu Y., Zhang Q., Liu C., Zhao S., Jiao B. Design, synthesis and biological activities of tetrandrine and fangchinoline derivatives as antitumer agents. Bioorg. Med. Chem. Lett. 2017;27:533\u2013536. doi: 10.1016/j.bmcl.2016.12.029.", "ArticleIdList": ["10.1016/j.bmcl.2016.12.029", "28057423"]}, {"Citation": "Li X., Yu N., Li J., Bai J., Ding D., Tang Q., Xu H. Novel \u201cCarrier-Free\u201d nanofiber codelivery systems with the synergistic antitumor effect of paclitaxel and tetrandrine through the enhancement of mitochondrial apoptosis. ACS Appl. Mater. Interfaces. 2020;12:10096\u201310106. doi: 10.1021/acsami.9b17363.", "ArticleIdList": ["10.1021/acsami.9b17363", "32027119"]}, {"Citation": "Liu R., Wang S., Fang S., Wang J., Chen J., Huang X., He X., Liu C. Liquid crystalline nanoparticles as an ophthalmic delivery system for tetrandrine: Development, characterization, and in vitro and in vivo evaluation. Nanoscale Res. Lett. 2016;11:254. doi: 10.1186/s11671-016-1471-0.", "ArticleIdList": ["10.1186/s11671-016-1471-0", "PMC4870510", "27188974"]}, {"Citation": "Li S., Ji Z., Zou M., Nie X., Shi Y., Cheng G. Preparation, Characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS PharmSciTech. 2011;12:1011. doi: 10.1208/s12249-011-9665-3.", "ArticleIdList": ["10.1208/s12249-011-9665-3", "PMC3167269", "21811889"]}, {"Citation": "Blaskovich M.A. Unusual amino acids in medicinal chemistry. J. Med. Chem. 2016;59:10807\u201310836. doi: 10.1021/acs.jmedchem.6b00319.", "ArticleIdList": ["10.1021/acs.jmedchem.6b00319", "27589349"]}, {"Citation": "Vig B.S., Huttunen K.M., Laine K., Rautio J. Amino acids as promoieties in prodrug design and development. Adv. Drug Deliv. Rev. 2013;65:1370\u20131385. doi: 10.1016/j.addr.2012.10.001.", "ArticleIdList": ["10.1016/j.addr.2012.10.001", "23099277"]}, {"Citation": "Wu Y., Cao D., Wang F., Ma L., Gao G., Chen L. Synthesis and evaluation of millepachine amino acid prodrugs with enhanced solubility as antitumor agents. Chem. Biol. Drug Des. 2015;86:559\u2013567. doi: 10.1111/cbdd.12507.", "ArticleIdList": ["10.1111/cbdd.12507", "25643726"]}, {"Citation": "Ninomiya M., Tanaka K., Tsuchida Y., Muto Y., Koketsu M., Watanabe K. Increased bioavailability of tricin-amino acid derivatives via a prodrug approach. J. Med. Chem. 2011;54:1529\u20131536. doi: 10.1021/jm1015457.", "ArticleIdList": ["10.1021/jm1015457", "21319803"]}, {"Citation": "Ran L., Li X., Liu M., Wang Q. Synthesis and antiproliferative activities of polymethoxyflavones aminoalkyl and amino acid derivatives. Heterocycl. Commun. 2020;26:68\u201375. doi: 10.1515/hc-2020-0010.", "ArticleIdList": ["10.1515/hc-2020-0010"]}, {"Citation": "Idzik K.R., Nodler K., Licha T. Efficient synthesis of readily water-soluble sulfonic Acid carbamates. Molecules. 2015;20:6856\u20136865. doi: 10.3390/molecules20046856.", "ArticleIdList": ["10.3390/molecules20046856", "PMC6272615", "25913926"]}, {"Citation": "Aggarwal A.K., Gupta M. Solubility and solution stability studies of different amino acid prodrugs of bromhexine. Drug Dev. Ind. Pharm. 2012;38:1319\u20131327. doi: 10.3109/03639045.2011.650644.", "ArticleIdList": ["10.3109/03639045.2011.650644", "22283553"]}, {"Citation": "Balimane P.V., Tamai I., Guo A., Nakanishi T., Kitada H., Leibach F.H., Tsuji A., Sinko P.J. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem. Biophys. Res. Commun. 1998;250:246\u2013251. doi: 10.1006/bbrc.1998.9298.", "ArticleIdList": ["10.1006/bbrc.1998.9298", "9753615"]}, {"Citation": "Sugawara M., Huang W., Fei Y.J., Leibach F.H., Ganapathy V., Ganapathy M.E. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J. Pharm. Sci. 2000;89:781\u2013789. doi: 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7.", "ArticleIdList": ["10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7", "10824137"]}, {"Citation": "Vale N., Ferreira A., Matos J., Fresco P., Gouveia M.J. Amino acids in the development of prodrugs. Molecules. 2018;23:2318. doi: 10.3390/molecules23092318.", "ArticleIdList": ["10.3390/molecules23092318", "PMC6225300", "30208629"]}, {"Citation": "Vig B., Rautio J. Amino acid prodrugs for oral delivery: Challenges and opportunities. Ther. Deliv. 2011;2:959\u2013962. doi: 10.4155/tde.11.75.", "ArticleIdList": ["10.4155/tde.11.75", "22826863"]}, {"Citation": "Bowden N.A., Sanders J.P.M., Bruins M.E. Solubility of the proteinogenic \u03b1-amino acids in water, ethanol, and ethanol-water mixtures. J. Chem. Eng. Data. 2018;63:488\u2013497. doi: 10.1021/acs.jced.7b00486.", "ArticleIdList": ["10.1021/acs.jced.7b00486", "PMC5846082", "29545650"]}, {"Citation": "Ali S.M., Hoemann M.Z., Aub\u00e9 J., Mitscher L.A., Georg G.I., McCall R., Jayasinghe L.R. Novel cytotoxic 3\u2019-(tert-butyl) 3\u2019-dephenyl analogs of paclitaxel and docetaxel. J. Med. Chem. 1995;38:3821\u20133828. doi: 10.1021/jm00019a012.", "ArticleIdList": ["10.1021/jm00019a012", "7562913"]}, {"Citation": "Zhang Y., Jiang Q., Zhang H., Jiang X.H. Determination of apparent solubility, apparent partition coefficient and dissociation constant of tetrandrine. West China J. Pharmaceut. Sci. 2013;28:501\u2013503."}, {"Citation": "Mouradov D., Sloggett C., Jorissen R.N., Love C.G., Li S., Burgess A.W., Arango D., Strausberg R.L., Buchanan D., Wormald S., et al. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. Cancer Res. 2014;74:3238\u20133247. doi: 10.1158/0008-5472.CAN-14-0013.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-0013", "24755471"]}, {"Citation": "Zhang J., Wang B. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo. Gynecol. Oncol. 2006;103:199\u2013206.", "ArticleIdList": ["16624393"]}, {"Citation": "Choi Y.J., Hur J.M., Lim S., Jo M., Kim D.H., Choi J.I. Induction of apoptosis by deinoxanthin in human cancer cells. Anticancer Res. 2014;34:1829\u20131835.", "ArticleIdList": ["24692716"]}, {"Citation": "Liu Y., Liu C., Tan T., Li S., Tang S., Chen X. Sinomenine sensitizes human gastric cancer cells to cisplatin through negative regulation of PI3K/AKT/Wnt signaling pathway. Anticancer Drugs. 2019;30:983\u2013990. doi: 10.1097/CAD.0000000000000834.", "ArticleIdList": ["10.1097/CAD.0000000000000834", "PMC6824511", "31609766"]}, {"Citation": "Sato A., Hiramoto A., Kim H.-S., Wataya Y. Anticancer strategy targeting cell death regulators: Switching the mechanism of anticancer floxuridine-induced cell death from necrosis to apoptosis. Int. J. Mol. Sci. 2020;21:5876. doi: 10.3390/ijms21165876.", "ArticleIdList": ["10.3390/ijms21165876", "PMC7461588", "32824286"]}, {"Citation": "Wu Y., Dong G., Sheng C. Targeting necroptosis in anticancer therapy: Mechanisms and modulators. Acta Pharm. Sin. B. 2020;10:1601\u20131618. doi: 10.1016/j.apsb.2020.01.007.", "ArticleIdList": ["10.1016/j.apsb.2020.01.007", "PMC7563021", "33088682"]}, {"Citation": "Wang N., Wang X., Tan H.-Y., Li S., Tsang C.M., Tsao S.-W., Feng Y. Berberine suppresses cyclin D1 expression through proteasomal degradation in human hepatoma cells. Int. J. Mol. Sci. 2016;17:1899. doi: 10.3390/ijms17111899.", "ArticleIdList": ["10.3390/ijms17111899", "PMC5133898", "27854312"]}, {"Citation": "Gelbert L.M., Cai S., Lin X., Sanchez-Martinez C., del Prado M., Lallena M.J., Torres R., Ajamie R.T., Wishart G.N., Flack R.S., et al. Preclinical characterization of the CDK4/6 inhibitor LY2835219: In-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. Investig. New Drugs. 2014;32:825\u2013837. doi: 10.1007/s10637-014-0120-7.", "ArticleIdList": ["10.1007/s10637-014-0120-7", "PMC4169866", "24919854"]}, {"Citation": "Wang Y., Liu X., Zhang D., Chen J., Liu S., Berk M. The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction. BMC Med. 2013;11:32. doi: 10.1186/1741-7015-11-32.", "ArticleIdList": ["10.1186/1741-7015-11-32", "PMC3606393", "23394076"]}, {"Citation": "Chen E., Chen C., Niu Z., Gan L., Wang Q., Li M., Cai X., Gao R., Katakam S., Chen H., et al. Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway. Signal Transduct. Target. Thery. 2020;5:216. doi: 10.1038/s41392-020-00257-w.", "ArticleIdList": ["10.1038/s41392-020-00257-w", "PMC7644758", "33154351"]}, {"Citation": "Liu T., Men Q., Wu G., Yu C., Huang Z., Liu X., Li W. Tetrandrine induces autophagy and differentiation by activating ROS and Notch1 signaling in leukemia cells. Oncotarget. 2015;6:7992\u20138006. doi: 10.18632/oncotarget.3505.", "ArticleIdList": ["10.18632/oncotarget.3505", "PMC4480730", "25797266"]}, {"Citation": "Bai X.-Y., Liu Y.-G., Song W., Li Y.-Y., Hou D.-S., Luo H.-M., Liu P. Anticancer activity of tetrandrine by inducing pro-death apoptosis and autophagy in human gastric cancer cells. J. Pharm. Pharmacol. 2018;70:1048\u20131058. doi: 10.1111/jphp.12935.", "ArticleIdList": ["10.1111/jphp.12935", "29770446"]}, {"Citation": "George D.M., Breinlinger E.C., Argiriadi M.A., Zhang Y., Wang J., Bansal-Pakala P., Duignan D.B., Honore P., Lang Q., Mittelstadt S., et al. Optimized protein kinase c \u03b8 (PKC\u03b8) inhibitors reveal only modest anti-inflammatory efficacy in a rodent model of arthritis. J. Med. Chem. 2015;58:333\u2013346. doi: 10.1021/jm5013006.", "ArticleIdList": ["10.1021/jm5013006", "25254961"]}, {"Citation": "Park H.J., Zhang Y., Georgescu S.P., Johnson K.L., Kong D., Galper J.B. Human umbilical vein endothelial cells and human dermal microvascular endothelial cells offer new insights into the relationship between lipid metabolism and angiogenesis. Stem Cell Rev. 2006;2:93\u2013102. doi: 10.1007/s12015-006-0015-x.", "ArticleIdList": ["10.1007/s12015-006-0015-x", "17237547"]}, {"Citation": "Fan H., Wei D., Zheng K., Qin X., Yang L., Yang Y., Duan Y., Xu Y., Hu L. Discovery of Dioxino[2,3-f]quinazoline derivative VEGFR-2 inhibitors exerting significant antipro-liferative activity in HUVECs and mice. Eur. J. Med. Chem. 2019;175:349\u2013356. doi: 10.1016/j.ejmech.2019.04.015.", "ArticleIdList": ["10.1016/j.ejmech.2019.04.015", "31096155"]}, {"Citation": "Soeda S., Kozako T., Iwata K., Shimeno H. Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: Its possible mechanism of action. Biochim. Biophys. Acta. 2000;1497:127\u2013134. doi: 10.1016/S0167-4889(00)00052-5.", "ArticleIdList": ["10.1016/S0167-4889(00)00052-5", "10838166"]}, {"Citation": "Lan J., Huang L., Lou H., Chen C., Liu T., Hu S., Yao Y., Song J., Luo J., Liu Y., et al. Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity. Eur. J. Med. Chem. 2018;143:1968\u20131980. doi: 10.1016/j.ejmech.2017.11.007.", "ArticleIdList": ["10.1016/j.ejmech.2017.11.007", "29133049"]}, {"Citation": "Hu S.C., Yang J., Chen C., Song J.R., Pan W.D. Design, Synthesis of novel tetrandrine-14-l-amino acid and tetrandrine-14-l-amino acid-urea derivatives as potential anti-cancer agents. Molecules. 2020;25:1738. doi: 10.3390/molecules25071738.", "ArticleIdList": ["10.3390/molecules25071738", "PMC7180913", "32283819"]}, {"Citation": "Zhou M., Wang M., Zhong R.-F., Liao X.-M., Deng L.-L., Xu G.-B., He X., Li J., Li Y.-J., Liu T., et al. Discovery and structure-activity relationship of auriculatone: A potent hepatoprotective agent against acetaminophen-induced liver injury. Bioorg. Med. Chem. Lett. 2017;27:3636\u20133642. doi: 10.1016/j.bmcl.2017.07.028.", "ArticleIdList": ["10.1016/j.bmcl.2017.07.028", "28729056"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "10"}, {"Year": "2022", "Month": "6", "Day": "16"}, {"Year": "2022", "Month": "6", "Day": "20"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "1", "Minute": "18"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "23"}], "PublicationStatus": "epublish", "ArticleIdList": ["35807286", "PMC9268013", "10.3390/molecules27134040", "molecules27134040"]}}], "PubmedBookArticle": []}